nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—HRH1—atherosclerosis	0.892	1	CbGaD
Tolazoline—Antazoline—HRH1—atherosclerosis	0.00213	1	CrCbGaD
Tolazoline—ADRA2A—Hemostasis—VEGFA—atherosclerosis	1.82e-05	0.000173	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP3—atherosclerosis	1.82e-05	0.000173	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGTR1—atherosclerosis	1.82e-05	0.000173	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF2—atherosclerosis	1.81e-05	0.000172	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—MTHFR—atherosclerosis	1.81e-05	0.000172	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—LPL—atherosclerosis	1.8e-05	0.000171	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—KNG1—atherosclerosis	1.8e-05	0.000171	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGTR1—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCL2—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—HMOX1—atherosclerosis	1.79e-05	0.00017	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PPARA—atherosclerosis	1.78e-05	0.000169	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PLG—atherosclerosis	1.78e-05	0.000169	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOB—atherosclerosis	1.76e-05	0.000167	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCL2—atherosclerosis	1.75e-05	0.000167	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PRKCG—atherosclerosis	1.75e-05	0.000166	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PIK3CG—atherosclerosis	1.75e-05	0.000166	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCL8—atherosclerosis	1.75e-05	0.000166	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PLG—atherosclerosis	1.74e-05	0.000165	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—EDN1—atherosclerosis	1.73e-05	0.000165	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—MAPK3—atherosclerosis	1.72e-05	0.000164	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AGT—atherosclerosis	1.72e-05	0.000163	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL5—atherosclerosis	1.72e-05	0.000163	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOB—atherosclerosis	1.71e-05	0.000163	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCL8—atherosclerosis	1.71e-05	0.000162	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SPP1—atherosclerosis	1.71e-05	0.000162	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCL8—atherosclerosis	1.7e-05	0.000161	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—APOE—atherosclerosis	1.69e-05	0.00016	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—LPL—atherosclerosis	1.68e-05	0.00016	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SOCS3—atherosclerosis	1.68e-05	0.00016	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—TGFB1—atherosclerosis	1.67e-05	0.000159	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—KNG1—atherosclerosis	1.67e-05	0.000159	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—CAV1—atherosclerosis	1.67e-05	0.000159	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—APOA1—atherosclerosis	1.67e-05	0.000158	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GSTM1—atherosclerosis	1.66e-05	0.000158	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGTR1—atherosclerosis	1.66e-05	0.000158	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SOCS3—atherosclerosis	1.65e-05	0.000157	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—AKT1—atherosclerosis	1.65e-05	0.000157	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PRKCG—atherosclerosis	1.64e-05	0.000155	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—LPL—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCL2—atherosclerosis	1.63e-05	0.000155	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP3—atherosclerosis	1.62e-05	0.000154	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL6—atherosclerosis	1.62e-05	0.000154	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PLG—atherosclerosis	1.62e-05	0.000154	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF2—atherosclerosis	1.62e-05	0.000154	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GPX1—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP3—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SPP1—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF2—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCL8—atherosclerosis	1.59e-05	0.000151	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PDGFB—atherosclerosis	1.58e-05	0.00015	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOB—atherosclerosis	1.57e-05	0.000149	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCL8—atherosclerosis	1.56e-05	0.000148	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CD36—atherosclerosis	1.55e-05	0.000147	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—EDN1—atherosclerosis	1.54e-05	0.000147	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MMP9—atherosclerosis	1.54e-05	0.000147	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AGT—atherosclerosis	1.54e-05	0.000146	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOB—atherosclerosis	1.54e-05	0.000146	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—AKT1—atherosclerosis	1.53e-05	0.000146	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SOCS3—atherosclerosis	1.53e-05	0.000146	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL5—atherosclerosis	1.53e-05	0.000146	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCL8—atherosclerosis	1.53e-05	0.000145	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—NFKB1—atherosclerosis	1.53e-05	0.000145	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PIK3CG—atherosclerosis	1.52e-05	0.000145	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—EDN1—atherosclerosis	1.52e-05	0.000144	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—LEP—atherosclerosis	1.51e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APOE—atherosclerosis	1.51e-05	0.000143	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL5—atherosclerosis	1.5e-05	0.000143	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MAPK8—atherosclerosis	1.5e-05	0.000143	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LPL—atherosclerosis	1.5e-05	0.000142	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—AKT1—atherosclerosis	1.5e-05	0.000142	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CAV1—atherosclerosis	1.5e-05	0.000142	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—APOA1—atherosclerosis	1.49e-05	0.000142	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP3—atherosclerosis	1.48e-05	0.000141	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PDGFB—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF2—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MTHFR—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LPL—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PPARG—atherosclerosis	1.47e-05	0.00014	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PRKCG—atherosclerosis	1.46e-05	0.000138	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARA—atherosclerosis	1.44e-05	0.000137	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—ESR1—atherosclerosis	1.44e-05	0.000137	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—INS—atherosclerosis	1.44e-05	0.000137	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AGT—atherosclerosis	1.44e-05	0.000137	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—AKT1—atherosclerosis	1.43e-05	0.000136	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOB—atherosclerosis	1.43e-05	0.000136	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PRKCG—atherosclerosis	1.43e-05	0.000136	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—F2—atherosclerosis	1.42e-05	0.000135	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SPP1—atherosclerosis	1.42e-05	0.000135	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL8—atherosclerosis	1.42e-05	0.000135	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL8—atherosclerosis	1.41e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—LEP—atherosclerosis	1.41e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOE—atherosclerosis	1.41e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—EDN1—atherosclerosis	1.41e-05	0.000134	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AGT—atherosclerosis	1.4e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL5—atherosclerosis	1.4e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CAV1—atherosclerosis	1.4e-05	0.000133	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—APOA1—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SPP1—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL8—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—VEGFA—atherosclerosis	1.39e-05	0.000132	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—STAT3—atherosclerosis	1.37e-05	0.00013	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOE—atherosclerosis	1.37e-05	0.00013	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LPL—atherosclerosis	1.37e-05	0.00013	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PIK3CG—atherosclerosis	1.36e-05	0.000129	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—CAV1—atherosclerosis	1.36e-05	0.000129	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—APOA1—atherosclerosis	1.35e-05	0.000129	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—ESR1—atherosclerosis	1.35e-05	0.000128	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—F2—atherosclerosis	1.33e-05	0.000126	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PRKCG—atherosclerosis	1.33e-05	0.000126	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—atherosclerosis	1.32e-05	0.000125	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PDGFB—atherosclerosis	1.31e-05	0.000125	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—MAPK3—atherosclerosis	1.31e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—MAPK3—atherosclerosis	1.3e-05	0.000124	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SPP1—atherosclerosis	1.29e-05	0.000123	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—INS—atherosclerosis	1.29e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PDGFB—atherosclerosis	1.29e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL8—atherosclerosis	1.29e-05	0.000122	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AGT—atherosclerosis	1.28e-05	0.000122	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PIK3CG—atherosclerosis	1.27e-05	0.000121	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TGFB1—atherosclerosis	1.27e-05	0.000121	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCL2—atherosclerosis	1.27e-05	0.000121	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—NOS3—atherosclerosis	1.26e-05	0.00012	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AGT—atherosclerosis	1.26e-05	0.000119	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—LEP—atherosclerosis	1.26e-05	0.000119	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOE—atherosclerosis	1.26e-05	0.000119	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IGF1—atherosclerosis	1.25e-05	0.000118	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CAV1—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—APOA1—atherosclerosis	1.24e-05	0.000118	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PIK3CG—atherosclerosis	1.24e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—LEP—atherosclerosis	1.23e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOE—atherosclerosis	1.23e-05	0.000117	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CAV1—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—MAPK3—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—APOA1—atherosclerosis	1.22e-05	0.000116	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—INS—atherosclerosis	1.2e-05	0.000114	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—ESR1—atherosclerosis	1.2e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PDGFB—atherosclerosis	1.2e-05	0.000114	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PPARG—atherosclerosis	1.19e-05	0.000113	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCL2—atherosclerosis	1.18e-05	0.000113	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—F2—atherosclerosis	1.18e-05	0.000113	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SERPINE1—atherosclerosis	1.18e-05	0.000113	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—ESR1—atherosclerosis	1.18e-05	0.000112	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—INS—atherosclerosis	1.17e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AGT—atherosclerosis	1.17e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IGF1—atherosclerosis	1.16e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—AKT1—atherosclerosis	1.16e-05	0.000111	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—F2—atherosclerosis	1.16e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—atherosclerosis	1.16e-05	0.00011	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOE—atherosclerosis	1.15e-05	0.000109	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—LEP—atherosclerosis	1.15e-05	0.000109	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CAV1—atherosclerosis	1.13e-05	0.000108	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PIK3CG—atherosclerosis	1.13e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—APOA1—atherosclerosis	1.13e-05	0.000108	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NOS3—atherosclerosis	1.13e-05	0.000107	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PIK3CG—atherosclerosis	1.11e-05	0.000106	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SERPINE1—atherosclerosis	1.11e-05	0.000105	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ESR1—atherosclerosis	1.09e-05	0.000104	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—MAPK3—atherosclerosis	1.09e-05	0.000103	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—F2—atherosclerosis	1.08e-05	0.000103	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—INS—atherosclerosis	1.07e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—atherosclerosis	1.07e-05	0.000102	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—MAPK3—atherosclerosis	1.07e-05	0.000101	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NOS3—atherosclerosis	1.06e-05	0.0001	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCL2—atherosclerosis	1.06e-05	0.0001	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—INS—atherosclerosis	1.05e-05	0.0001	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IGF1—atherosclerosis	1.04e-05	9.86e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCL2—atherosclerosis	1.04e-05	9.84e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PIK3CG—atherosclerosis	1.03e-05	9.82e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—NOS3—atherosclerosis	1.03e-05	9.75e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IGF1—atherosclerosis	1.02e-05	9.68e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—atherosclerosis	1e-05	9.53e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—MAPK3—atherosclerosis	9.9e-06	9.4e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SERPINE1—atherosclerosis	9.86e-06	9.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—INS—atherosclerosis	9.78e-06	9.29e-05	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—AKT1—atherosclerosis	9.69e-06	9.2e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SERPINE1—atherosclerosis	9.67e-06	9.19e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCL2—atherosclerosis	9.62e-06	9.14e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—atherosclerosis	9.58e-06	9.1e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—atherosclerosis	9.54e-06	9.06e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IGF1—atherosclerosis	9.46e-06	8.99e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NOS3—atherosclerosis	9.41e-06	8.94e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—atherosclerosis	9.38e-06	8.91e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—atherosclerosis	9.37e-06	8.9e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NOS3—atherosclerosis	9.23e-06	8.77e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MMP9—atherosclerosis	9.07e-06	8.62e-05	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—AKT1—atherosclerosis	9.05e-06	8.6e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SERPINE1—atherosclerosis	8.99e-06	8.54e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—NFKB1—atherosclerosis	8.98e-06	8.53e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—atherosclerosis	8.91e-06	8.46e-05	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—AKT1—atherosclerosis	8.84e-06	8.4e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAPK8—atherosclerosis	8.82e-06	8.38e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—AKT1—atherosclerosis	8.8e-06	8.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NOS3—atherosclerosis	8.58e-06	8.15e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MMP9—atherosclerosis	8.47e-06	8.05e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—NFKB1—atherosclerosis	8.38e-06	7.97e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—atherosclerosis	8.35e-06	7.93e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAPK8—atherosclerosis	8.24e-06	7.83e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—AKT1—atherosclerosis	8.22e-06	7.81e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—atherosclerosis	8.19e-06	7.78e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—VEGFA—atherosclerosis	8.15e-06	7.74e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—atherosclerosis	8.07e-06	7.66e-05	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—AKT1—atherosclerosis	8.06e-06	7.66e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—atherosclerosis	7.94e-06	7.54e-05	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—AKT1—atherosclerosis	7.91e-06	7.52e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—atherosclerosis	7.79e-06	7.4e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—MAPK3—atherosclerosis	7.71e-06	7.32e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—atherosclerosis	7.61e-06	7.23e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—VEGFA—atherosclerosis	7.61e-06	7.23e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MMP9—atherosclerosis	7.55e-06	7.17e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—atherosclerosis	7.53e-06	7.16e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TGFB1—atherosclerosis	7.48e-06	7.1e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—NFKB1—atherosclerosis	7.47e-06	7.1e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MMP9—atherosclerosis	7.41e-06	7.04e-05	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—AKT1—atherosclerosis	7.35e-06	6.98e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAPK8—atherosclerosis	7.34e-06	6.98e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—NFKB1—atherosclerosis	7.33e-06	6.96e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—AKT1—atherosclerosis	7.32e-06	6.96e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—atherosclerosis	7.24e-06	6.87e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAPK8—atherosclerosis	7.2e-06	6.84e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—MAPK3—atherosclerosis	7.2e-06	6.84e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—AKT1—atherosclerosis	7.18e-06	6.83e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TGFB1—atherosclerosis	6.98e-06	6.64e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MMP9—atherosclerosis	6.88e-06	6.54e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—NFKB1—atherosclerosis	6.81e-06	6.47e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—VEGFA—atherosclerosis	6.78e-06	6.44e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—atherosclerosis	6.71e-06	6.38e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAPK8—atherosclerosis	6.69e-06	6.36e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—AKT1—atherosclerosis	6.68e-06	6.34e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—VEGFA—atherosclerosis	6.65e-06	6.32e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—atherosclerosis	6.59e-06	6.26e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—MAPK3—atherosclerosis	6.41e-06	6.09e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MAPK3—atherosclerosis	6.29e-06	5.98e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TGFB1—atherosclerosis	6.22e-06	5.91e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—VEGFA—atherosclerosis	6.18e-06	5.87e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—atherosclerosis	6.12e-06	5.81e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TGFB1—atherosclerosis	6.11e-06	5.8e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MAPK3—atherosclerosis	5.85e-06	5.55e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—AKT1—atherosclerosis	5.81e-06	5.52e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TGFB1—atherosclerosis	5.67e-06	5.39e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—atherosclerosis	5.63e-06	5.35e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—atherosclerosis	5.26e-06	5e-05	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—AKT1—atherosclerosis	5.2e-06	4.94e-05	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—AKT1—atherosclerosis	4.85e-06	4.61e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—AKT1—atherosclerosis	4.72e-06	4.48e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—atherosclerosis	4.69e-06	4.45e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—atherosclerosis	4.6e-06	4.37e-05	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—AKT1—atherosclerosis	4.33e-06	4.11e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—atherosclerosis	4.27e-06	4.06e-05	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—AKT1—atherosclerosis	4.24e-06	4.03e-05	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—AKT1—atherosclerosis	3.94e-06	3.75e-05	CbGpPWpGaD
